BrightSpring Health Services, Inc. (BTSG)
NASDAQ: BTSG · Real-Time Price · USD
22.35
-0.47 (-2.06%)
At close: May 12, 2025, 4:00 PM
22.60
+0.25 (1.12%)
After-hours: May 12, 2025, 7:59 PM EDT
BTSG Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for BTSG stock have an average target of 22.75, with a low estimate of 18 and a high estimate of 30. The average target predicts an increase of 1.79% from the current stock price of 22.35.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BTSG stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 | 4 |
Buy | 5 | 5 | 5 | 5 | 5 | 4 |
Hold | 2 | 2 | 2 | 2 | 2 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 13 | 13 | 13 | 13 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Buy Maintains $20 → $25 | Buy | Maintains | $20 → $25 | +11.86% | May 9, 2025 |
UBS | UBS | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +34.23% | Jan 29, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | -10.51% | Dec 17, 2024 |
CJS Securities | CJS Securities | Buy Initiates $27 | Buy | Initiates | $27 | +20.81% | Dec 12, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $19 → $21 | Strong Buy | Maintains | $19 → $21 | -6.04% | Dec 11, 2024 |
Financial Forecast
Revenue This Year
12.20B
from 11.27B
Increased by 8.26%
Revenue Next Year
13.53B
from 12.20B
Increased by 10.89%
EPS This Year
0.58
from -0.09
EPS Next Year
0.82
from 0.58
Increased by 41.02%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.7B | 14.9B | 17.2B | ||
Avg | 12.2B | 13.5B | 15.1B | ||
Low | 11.5B | 12.5B | 13.5B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 21.7% | 21.9% | 27.0% | ||
Avg | 8.3% | 10.9% | 11.7% | ||
Low | 1.9% | 2.2% | 0.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.79 | 1.04 | 1.26 | ||
Avg | 0.58 | 0.82 | 1.08 | ||
Low | 0.42 | 0.64 | 0.82 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 77.9% | 52.9% | ||
Avg | - | 41.0% | 30.7% | ||
Low | - | 9.0% | -0.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.